Lidiannie Otero de Leon
Internal Medicine · Cayey, PRNPI 1639630270
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.8% of the total across 200 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 10.1% — the pattern of someone who eats at a lot of different presentations. Among internal medicine clinicians in PR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 200 payments — averaging $33.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$681
- Tempus AI, Inc$534
- Gilead$480
- PBG Puerto Rico LLC$438
- Sanofi$398
- Rigel Pharmaceuticals, Inc.$371
- plus $4K from 32 others
What the payments were for
- Food & beverage$6,67899%
- Education$821%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 11 | $681 |
| Tempus AI, Inc | 16 | $534 |
| Gilead | 4 | $480 |
| PBG Puerto Rico LLC | 22 | $438 |
| Sanofi | 5 | $398 |
| Rigel Pharmaceuticals, Inc. | 3 | $371 |
| Merck | 15 | $292 |
| AbbVie | 13 | $285 |
| Novartis | 12 | $281 |
| Genentech USA, Inc. | 14 | $273 |
| Sobi, Inc | 6 | $244 |
| Johnson & Johnson | 11 | $222 |
| AstraZeneca | 10 | $203 |
| Incyte Corporation | 3 | $187 |
| Pfizer | 5 | $164 |
| E.r. Squibb & Sons, L.L.C. | 7 | $160 |
| Servier Pharmaceuticals LLC | 2 | $148 |
| GSK | 4 | $145 |
| Regeneron Healthcare Solutions, Inc. | 6 | $144 |
| ADC Therapeutics America, Inc. | 2 | $144 |
| Genmab U.S., Inc. | 2 | $132 |
| Lilly USA, LLC | 1 | $100 |
| Adaptive Biotechnologies Corporation | 1 | $82 |
| Exelixis Inc. | 3 | $82 |
| Telix Pharmaceuticals | 3 | $71 |
| Eli Lilly Export S.A. Puerto Rico Branch | 3 | $66 |
| Karyopharm Therapeutics Inc. | 1 | $65 |
| Taiho Oncology, Inc. | 2 | $49 |
| AVEO Pharmaceuticals, Inc. | 2 | $46 |
| Jazz Pharmaceuticals Inc. | 2 | $41 |
| Eisai Inc. | 2 | $38 |
| EMD Serono, Inc. | 1 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $36 |
| Seagen Inc. | 1 | $33 |
| Mirati Therapeutics, Inc. | 1 | $25 |
| Caris MPI, Inc. | 1 | $21 |
| Springworks Therapeutics, Inc. | 1 | $21 |
| Blueprint Medicines Corporation | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,760 in reported general payments places this provider in the 95th percentile of 1,043 internal medicine providers in Puerto Rico.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Acyclovir | 20 | $269 |
| Levofloxacin | 11 | $137 |
| Pantoprazole Sodium | 12 | $70 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Cayey
- Nelson VallejoLas Piedras$621K
- Ricardo FernandezSan Juan$351K
- Ronald Collazo PaganManati$206K
- Angel VinuelaDorado$182K
- Julio JimenezSan Lorenzo$99K
- Luis Negron GarciaSan German$24K
- Jorge Torres OlmedaCoto Laurel$23K
- Norma SalgadoSan Juan$21K
- Victor Gordo GonzalezSan Juan$21K
- Luis Rivera ColonRio Piedras$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.